Spezielle therapeutische Probleme im höheren Alter

Adams MR, Kaplan JR, Manuck SB et al (1990) Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys: lack of an effect of added progesterone. Arteriosclerosis 10:1051–1057PubMedGoogle Scholar

Akiyama T, Pawitan Y, Campbell WB et al (1992) Effects of advancing age on the efficacy and side effects of antiarrhythmic drugs in post-myocardial infarction patients with ventricular arrhythmias. The CAST Investigators. J Am Ger Soc 40:666–672Google Scholar

Akiyama T, Pawitan Y, Greenberg H et al (1991) Increased risk of death and cardiac arrest from encainide and flecainide in patients after non-Q-wave acute myocardial infarction in the Cardiac Arrhythmia Suppression Trial. CAST Investigators. Am J Cardiol 68:1551–1555CrossRefPubMedGoogle Scholar

Albers GW, Atwood JE, Hirsh J et al (1991) Stroke prevention in nonvalvular atrial fibrillation. Ann Intern Med 115:727–736PubMedGoogle Scholar

Albers GW, Dalen JE, Laupacis A et al (2001) Antithrombotic therapy in atrial fibrillation. Chest 119:194S–206SCrossRefPubMedGoogle Scholar

Amiodarone Trials Metaanalysis Investigators (1997) Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: metaanalysis of individual data from 6500 patients in randomized trials. Lancet 350:1417–1424Google Scholar

Applebaum GE, King JE, Finucane TE (1990) The outcome of CPR initiated in nursing homes. J Am Geriatr Soc 38:197–200PubMedGoogle Scholar

Atrial Fibrillation Investigators (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from 5 randomized trials. Arch Intern Med 154:1449–1457Google Scholar

Atwood EJ (1992) Exercise hemodynamics of atrial fibrillation. In: Falk RA, Podrid PJ (eds) Atrial Fibrillation. Raven Press Ltd, New York, NY; pp 145–163Google Scholar

Atwood JE, Myers J, Quaglietti S et al (1999) Effect of betaxolol on the hemodynamic, gas exchange, and cardiac output response to exercise in chronic atrial fibrillation. Chest 115:1175–1180CrossRefPubMedGoogle Scholar

Austin MA, Hokanson JE, Edwards KL (1998) Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 81:7B–12BCrossRefPubMedGoogle Scholar

AVID Investigators (1997) A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from nearfatal ventricular arrhythmias. N Engl J Med 337:1576–1583Google Scholar

Barrett-Conner E (1991) Postemnopausal estrogen and prevention bias. Ann Intern Med 115:455–456PubMedGoogle Scholar

Bass KM, Newschaffer CJ, Klag MJ et al (1993) Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med 98:83–90Google Scholar

Basta L, Plunkitt K, Shashy R et al (1998) Cardiopulmonary resuscitation in the elderly: defining the limits of appropriateness. Am J Geriatr Cardiol 7:46–55PubMedGoogle Scholar

Berns MAM, De Vries JHM, Ktan MB (1988) Determinants of the increase of serum cholesterol with age: a longitudinal study. Int J Epidemiol 17:789–796PubMedGoogle Scholar

Beyth R, Antani M, Covinsky K (1996) Why isn’t warfarin prescribed to patients with nonrheumatic atrial fibrillation? J Gen Intern Med 11:721–728PubMedGoogle Scholar

Boriani G, Biffi M, Capucci A et al (1998) Oral loading with propafenone: a placebo-controlled study in elderly and non-elderly patients with recent onset atrial fibrillation. Pace 21:2465–2469PubMedGoogle Scholar

Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators (1990) The effect of low-dose warfarin on the risk of stroke in nonrheumatic atrial fibrillation. N Engl J Med 323:1505–1511Google Scholar

Brignole M, Gianfranchi L, Menozzi C et al (1994) Influence of atrioventricular junction radiofrequency ablation in patients with chroic atrial fibrillation and flutter on quality of life and cardiac performance. Am J Cardiol 74:242–246CrossRefPubMedGoogle Scholar

Brignole M, Gianfranchi L, Menozzi C et al (1997) Assessment of atrioventricular junction ablation and DDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation. Circulation 96:2617PubMedGoogle Scholar

Brignole M, Menozzi C, Gianfranchi L et al (1998) Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation. Circulation 98:953–960PubMedGoogle Scholar

Brymer C, Gangbar E, O’Rourke K et al (1989) Age as a determinant of cardiopulmonary resuscitation outcome in the coronary care unit. J Am Geriatr Soc 43:634–637Google Scholar

Bungard TJ, Ghali WA, Teo KK et al (2000) Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 160:41–46CrossRefPubMedGoogle Scholar

Bush TL (1996) Evidence for primary and secondary prevention of coronary artery disease in women taking oestrogen replacement therapy. Eur Heart J 17(suppl D):9–14Google Scholar

Byington RP, Davis BR, Plehn JF (2001) Reduction of stroke events with pravastatin. The Prospective Pravastatin Pooling (PPP) Project. Circulation 103:387–392PubMedGoogle Scholar

Cairns J, Connolly S, Roberts R et al, for the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators (1997) Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations: CAMIAT. Lancet 349:675–682CrossRefPubMedGoogle Scholar

Caplan L (1996) Cerebrovascular disease and stroke. In: Cassel CK, Cohen HJ, Larson EG et al (eds) Geriatric Medicine, 3^rd edn Springer, New York, NY, p 923Google Scholar

Carlson M, Gold M, Ip J et al (2001) ADOPT-A Trial. Dynamic atrial overdrive pacing decreases symptomatik atrial arrhythmia burden in patients with sinus node dysfunction (abstract no. 1825). Circulation 104(suppl):II383Google Scholar

Carroll K, Majeed A (2001) Comorbidity associated with atrial fibrillation: a general practice-based study. Br J Gen Pract 51:884–886, 889-891PubMedGoogle Scholar

Cevher O, Arshad J, Friedman P et al (2001) Long term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med 334:14:1043–1051Google Scholar

Cobbe SM, Dalziel K, Ford I et al (1996) Survival of 1476 patients initially resuscitated from out-of-hospital cardiac arrest. Br Med J 312:1633–1637Google Scholar

Cohen N, Almoznino-Sarafian D, Alon I et al (2000) Warfarin for stroke prevention still underused in atrial fibrillation. Stroke 31:1217–1222PubMedGoogle Scholar

Connolly SJ, Laupacis A, Gent M et al (1991) Canadian Atrial Fibrillation Anticoagulation (CAFA) study. J Am Coll Cardiol 18:1255–1262Google Scholar

Coplen SE, Antman EM, Berlin JA et al (1990) Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A metaanalysis of randomized control trials. Circulation 82:1106–1116PubMedGoogle Scholar

Council on Ethical and Judicial Affiars. American Medical Association (1991) Guidelines for appropriate use of do not resuscitate orders. JAMA 265:1868–1871Google Scholar

Cushman M, Legault C, Barrett-Conner E et al (1999) Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Intervention (PEPI) study. Circulation 100:717–722PubMedGoogle Scholar

Dautzenberg PL, Bezemer PD (1991) Quantitative and qualitative aspects of cardiopulmonary resuscitation in aged in-patients. Neth J Med 39:366–372PubMedGoogle Scholar

Dayer M, Harmann SMC (2002) Special problems with antiarrhythmic drugs in the elderly: safety, tolerability, and efficacy. Am J Geriatr Cardiol 11: 370–375, 379PubMedGoogle Scholar

De Simone A, Stabile G, Vitale DF et al (1999) Pre-treatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion. J Am Coll Cardiol 34:810–814CrossRefPubMedGoogle Scholar

De Vreed-Swagemakers JJ, Gorgels AP, Dubois-Arbouw WI et al (1997) Out-of-hospital cardiac arrest in the 1990s: a population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol 30:1500–1505CrossRefPubMedGoogle Scholar

Deedwania PC, Singh BN, Ellenbogen K et al (1998) Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the Veterans Affairs Congestive Heart Failure Survival Trail of Antiarrhythmic Therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators. Circulation 98:2574–2579PubMedGoogle Scholar

DeSilvey DL (2003) MADIT II: lessons to learn. Am J Geriatr Cardiol 12:214PubMedGoogle Scholar

Dhond AJ, Michelena HI, Ezekowitz MD (2003) Anticoagulation in the elderly. Am J Geriatr Cardiol 12:243–250PubMedGoogle Scholar

DiBianco R, Morganroth J, Freitag JA et al (1984) Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin. Am Heart J 108:1121–1127CrossRefPubMedGoogle Scholar

Diem SJ, Lantos JD, Tulsky JA (1996) Cardiopulmonary resuscitation on television. Miracles and misinformation. N Eng J Med 334:1578–1582CrossRefGoogle Scholar

Doval HC, Nul DR, Vancelli HO et al (1994) Randomized trial of low-dose amiodarone in severe congestive heart failure. Lancet 344:493–498CrossRefPubMedGoogle Scholar

Downs JR, Clearfield M, Weis S et al (1998) Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279:1615–1522CrossRefPubMedGoogle Scholar

Dries DL, Waclawiw MA, Domanski M (1996) Antiplatelet and anticoagulant therapy reduce the risk of sudden death in the SOLVD prevention and treatment trials. Pacing Clin Electrophysiol 19:602Google Scholar

Espeland MA, Applegat W, Furberg CD et al (1995) Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study. Am J Epidemiol 142:1011–1019PubMedGoogle Scholar

European Atrial Fibrillation Trial Study Group (1993) Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet 342:1255–1262Google Scholar

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III). JAMA 285:2486–2497Google Scholar

Ezekowitz MD, Bridgers SL, James KE et al (1992) Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation: Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med 327:1406–1412PubMedGoogle Scholar

Ezekowitz MD, Levine JA (1999) Preventing strokes in patients with atrial fibrillation. JAMA 281:1830–1835CrossRefPubMedGoogle Scholar

Falk RH, Knowiton AA, Bernard SA et al (1987) Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial. Ann Intern Med 106:503–506PubMedGoogle Scholar

Fiore LD, Ezekowitz MD, Brophy MT et al (2002) Department of Veterans Affairs Cooperative Studies Program Clinical Trial coparin combined warfarin and aspirin with aspirin alone in survivors in acute myocardial infarction: primary results of the CHAMP study. Circulation 105:557–563CrossRefPubMedGoogle Scholar

Fischer M, Fischer NJ, Schuttler J (1997) One-year survival after out-of-hospital cardiac arrest in Bonn city: outcome report according to the „Utstein style“. Resuscitation 33:233–243CrossRefPubMedGoogle Scholar

Flaker GC, Blackshear JL, McBride R et al (1992) Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. Am J Geriatr Cardiol 20:527–532Google Scholar

Fresco C, Proclemer A, Pavan A et al (1996) Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2-Investigators. Clin Cardiol 19:409–412PubMedGoogle Scholar

Furberg CD, Psaty BM, Meyer JV (1996) Nifedipine: related increase in mortality in patients with coronary artery disease. Circulation 92:1326–1331Google Scholar

Fuster V, Ryden LE, Asinger RW et al (2001) ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Converences (Committee to Develop Guidelines for the Management of Patients with Atrial Firbrillation). J Am Coll Cardiol 38:1231–1265CrossRefPubMedGoogle Scholar

Ghusn HF, Teasdale TA, Pepe PE et al (1995) Older nursing home residents have a cardiac arrest survival rate similar to that of older persons living in the community. J Am Geriatr Soc 43:520–527PubMedGoogle Scholar

Go AS, Hylek EM, Philips KA et al (2001) Prevalence of diagnosed atrial fibrillation in adults. JAMA 285:2370–2375CrossRefPubMedGoogle Scholar

Grundy SM, Vega GL, Bilheimer DW (1985) Kinetic mechanisms determining variability in low density lipoprotein levels and rise with age. Arteriosclerosis 5: 623–630PubMedGoogle Scholar

Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:7–22Google Scholar

Herrington DM, Rboussin DM, Brosnihan KB et al (2000) Effects of estrogen replacement on the progression of coronary artery atherosclerosis. N Engl J Med 343:522–529CrossRefPubMedGoogle Scholar

Hough JL, Zilversmit DB (1986) Effect of 17-beta estradiol on aortic cholesterol content and metabolism in cholesterol-fed rabbits. Arteriosclerosis 6:57–63PubMedGoogle Scholar

Hsia J, Simon JA, Lin F et al (2000) Peripheral arterial disease in a randomized trial of estrogen with progestin in women with coronary heart disease: the Heart and Estrogen/Progestin Replacement Study. Circulation 102:2228–2232PubMedGoogle Scholar

Huang DT, Monahan KM, Zimetbaum P et al (1998) Hybrid pharmacologic and ablative therapy: a novel and effective approach for the management of atrial fibrillation. J Cardiovasc Electrophysiol 9(5):462–469PubMedGoogle Scholar

Hulley S, Grady D, Bush T et al, for the Heart and Estrogen/Progestin Replacement Study (HERS) Research Group (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280:605–613CrossRefPubMedGoogle Scholar

Hunt D, Young P, Simes J et al (2001) Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID Trial. Ann Intern Med 134:931–940PubMedGoogle Scholar

Hurlen M, Abdelnoor M, Smith P et al (2002) Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 347:969–974CrossRefPubMedGoogle Scholar

Juchems R, Wahlig G, Grese W (1993) Influence of age on the survival rate of out-of-hospital and in-hospital resuscitation. Resuscitation 26:23–29CrossRefPubMedGoogle Scholar

Julian DG, Camm AJ, Frangini G et al, for the European Myocardial Infarct Amiodarone Trial Investigators (1997) Randomized trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 349:667–674CrossRefPubMedGoogle Scholar

Kannel WB, Abbot RD, Savage DD et al (1982) Epidemiologic features of chronic atrial fibrillation: the Framingham Study. N Engl J Med 306:1018–1022PubMedGoogle Scholar

Kannel WB, Neaton JD, Wentworth D et al (1986) Overall and coronary heart disease mortality rates in relation major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial. Am Heart J 112:825–836CrossRefPubMedGoogle Scholar

Kerin NZ, Faitel K, Naini M (1996) The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs. quinidine for conversion of atrial fibrillation. Arch Intern Med 156:49–53CrossRefPubMedGoogle Scholar

Kober L, Torp Pedersen C, Carlsen J et al (1995) A clinical trial of the ACE inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 333:1670–1676CrossRefPubMedGoogle Scholar

Kornfiled HJ (1992) Survival after out-of-hospital cardiac arrest. JAMA 267:2186CrossRefGoogle Scholar

Kulbertus HE, De Leval-Rutten F, Barsch P et al (1983) Is lone atrial fibrillation benign in the elderly? J Am Coll Cardiol (abstract)1:583Google Scholar

Laupacis A, Albers G, Dalen J et al (1999) Antithrombotic therapy in atrial fibrillation. Chest 114:579S–589SGoogle Scholar

Lee SH, Chen SA, Tai CT et al (1998) Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation. J Am Coll Cardiol 31:637–644CrossRefPubMedGoogle Scholar

Levine MN, Raskob G, Landefeld S et al (1998) Hemorrhagic complications of anticoagulant treatment. Chest 114:511S–523SPubMedGoogle Scholar

Levine PA, Sperzel J, Florio J et al (2000) Device management of paroxysmal atrial fibrillation using dynamic atrial overdrive algorithm. Herzschrittmacher 20: 86–95Google Scholar

Limacher MC (2002) Issues of hormone replacement therapy and cardiovascular disease for elderly women. Am J Geriatr Cardiol 11:217–222PubMedGoogle Scholar

Lipid Research Clinics Program Epidemiology Committee (1979) Plasma lipid distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study. Circulation 60:427–439Google Scholar

Lipkin DP, Frenneaux M, Stewart R et al (1988) Delayed improvement in exercise capacity in patients after cardioversion of atrial fibrillation to sinus rhythm. Br Heart J 59:572–577PubMedGoogle Scholar

Manolio TA, Pearson TA, Wenger NK et al (1992) Cholesterol and heart disease in older persons and women: review of an NHLBI workshop. Ann Epidemiol 2: 161–176PubMedGoogle Scholar

Manson JE, Martin KA (2001) Postmenopausal hormone-replacement therapy. N Engl J Med 346:34–40CrossRefGoogle Scholar

Man-Son-Hing M, Nichol G, Lau A et al (1999) Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch Intern Med 159:677–685CrossRefPubMedGoogle Scholar

Mason JW, for the Electrophysiologic Study vs Electrocardiographic Monitoring Investigators (1993) A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med 329:452–458CrossRefPubMedGoogle Scholar

Matthews KA, Kuller LH, Wing RR et al (1996) Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol 143:971–978PubMedGoogle Scholar

McCue J (1995) The naturalness of dying. JAMA 273(13):1039–1043CrossRefPubMedGoogle Scholar

Miettinen TA, Pyorala K, Olsson AG et al (1997) Cholesterol lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S). Circulation 96:4211–4218PubMedGoogle Scholar

Mosca L, Barrett-Connor E, Wenger NK et al (2001) Design and methods of a Reloxifene Use for The Heart (RUTH) study. Am J Cardiol 88:392–395CrossRefPubMedGoogle Scholar

Moss A, Hall J, Cannon D et al (1996) Improved survival with an implantable defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia. N Engl J Med 335:1933–1940CrossRefPubMedGoogle Scholar

Moss AJ, Zareba W, Hall WJ et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883CrossRefPubMedGoogle Scholar

Naccarelli GV, Dorian P, Hohnloser SH et al (1996) Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. Am J Cardiol 77:53A–59ACrossRefPubMedGoogle Scholar

Ott A, Breteler M, De Bruyne MC et al (1997) Atrial fibrillation and dementia in a population-based study. Stroke 28:316–321PubMedGoogle Scholar

Pappone C, Oreto G, Rosanio S et al (2001) Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation 104:2539–2544PubMedGoogle Scholar

Parhofer KG, Göke B (2003) Therapie der Hyperlipoproteinämie im Alter. Internist 44:968–976CrossRefPubMedGoogle Scholar

Peterson P, Boysen G, Godtfredsen J et al (1989) Placebo controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillatin: the Copenhagen AFASAK Study. Lancet 1:175–179CrossRefPubMedGoogle Scholar

Pick R, Stamler J, Robard S et al (1952) The inhibition of coronary atherosclerosis by estrogens in cholesterol-fed chicks. Circulation 6:276–280PubMedGoogle Scholar

Pietersen AH, Hellemann H (1991) Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter. Am J Cardiol 67:713–717CrossRefPubMedGoogle Scholar

Pinamonti B, Lenarda AD, Sinagra G et al (1993) Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: clinical, echocardiographic and hemodynamic correlations and prognostic implications. J Am Coll Cardiol 22:808–815PubMedGoogle Scholar

Purcz T, Reuter W (2000) Lipoproteinstoffwechsel beim alten Menschen. In: Schwandt P, Richter WO, Parhofer KG (Hrsg) Handbuch der Fettstoffwechsel störungen, 2. Aufl. Schattauer, Stuttgart, S 797–810Google Scholar

Rabkin MT, Dillerman G, Rice NR (1976) Orders not to resuscitate. N Engl J Med 7:364–366Google Scholar

Rawles JM, Metcalfe MJ, Jenings K (1990) Time of occurence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin. Br Heart J 63:225–227PubMedGoogle Scholar

Reaven GM (1988) Banting lecture. Role of insulin resistance in human disease. Diabetes 37:1595–1607PubMedGoogle Scholar

Roque M, Heras M, Roig E et al (1998) Short-term effects of transdermal estrogen therapy on coronary vascular reactivity in postmenopausal women with angina pectoris and normal results on coronary angiograms. J Am Coll Cardiol 31:139–143CrossRefPubMedGoogle Scholar

Sacks FM, Pfeffer MA, Moye LA et al (1996) The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrents Events Trial. N Engl J Med 335:1001–1009CrossRefPubMedGoogle Scholar

Sacks FM, Tonkin AM, Shepherd J et al (2000) Effect of pravastatin in coronary disease events in subgroups defined by coronary risk factors. The Prospective Pravastatin Pooling Project. Circulation 102:1893–1900PubMedGoogle Scholar

Saksena S, Prakash A, Hill M et al (1996) Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing. J Am Coll Cardiol 28:687–694CrossRefPubMedGoogle Scholar

Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383–1389Google Scholar

Schneider II AP 2rd, Nelson DJ, Brown DD (1993) In-hospital cardiopulmonary resuscitation: a 30-year review. J Am Board Fam Pract 6:91–101PubMedGoogle Scholar

Sedgwick ML, Dalziel K et al (1993) Performance of an established system of first responder out-of-hospital defibrillation. The results of the second year of the Heartstart Scotland Project in the ‚Utstein Style’. Resuscitation 26:75–88CrossRefPubMedGoogle Scholar

Sheperd J, Blauw GJ, Murphy MB et al (2002) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360:1623–1628CrossRefPubMedGoogle Scholar

Shepherd J, Cobbe SM, Ford I et al (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotkland Coronary Prevention Study Group. N Engl J Med 333:1301–1307CrossRefPubMedGoogle Scholar

Simon JA, Hsia J, Cauley JA et al (2001) Postmenopausal hormone therapy and risk of stroke: the Heart and Estrogen-progestin Replacement Study (HERS). Circulation 103:638–642PubMedGoogle Scholar

Singh SN (1998) Antiarrhythmic drug therapy of ventricular tachycardia in the elderly: lessons form clinical trials. Am J Geriatr Cardiol 7:56–59PubMedGoogle Scholar

Singh SN, Fletcher RD, Fisher SG et al (1995) Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 333:77–82CrossRefPubMedGoogle Scholar

Sodermark T, Jonsson B, Olsson A et al (1975) Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter. A multicentre study from Stockholm. Br Heart J 37:486–492PubMedGoogle Scholar

Stafford RS (1998) Recent national patterns of warfarin use in atrial fibrillation. Circulation 97:1231–1233PubMedGoogle Scholar

Stafford RS, Singer DE (1996) National patterns of warfarin use in atrial fibrillation. Arch Intern Med 156:2537–2541CrossRefPubMedGoogle Scholar

Stamler J, Wentworth D, Neaton JD (1986) Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screens of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 256:2823–2828CrossRefPubMedGoogle Scholar

Stampfer MJ, Colditz GA (1991) Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 20:47–63CrossRefPubMedGoogle Scholar

Stroke Prevention in Atrial Fibrillation Investigators (1990) Design of a multicenter randomized trial for the Stroke Prevention in Atrial Fibrillation Study. Stroke 21: 538–545Google Scholar

Stroke Prevention in Atrial Fibrillation Investigators (1991) Stroke Prevention in Atrial Fibrillation Study: final results. Circulation 84:527–539Google Scholar

Stroke Prevention in Atrial Fibrillation Investigators (1996) Adjusted-dose warfarin versus low intensity, fixed dose warfarin plus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomized clinical trials. Lancet 348:633–638Google Scholar

Strokes Prevention in Atrial Fibrillation Investigators (1994) Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: SPAF II Study. Lancet 343:687–691Google Scholar

Sullivan JM, Zwaag RV, Hughes JP et al (1990) Estrogen replacement and coronary artery disease: effect on survival in postmenopausal women. Arch Intern Med 150:2557–2562CrossRefPubMedGoogle Scholar

SUPPORT Principal Investigators (1995) A controlled trial to improve care for seriously ill hospitalized patients: the study to understand prognoses and preferences for outcomes and treatment (SUPPORT) JAMA 274:1591–1598Google Scholar

The AFFIRM Investigators (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825–1833Google Scholar

The CAST Investigators (1989) Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocarcial infarction. N Engl J Med 321:406–412Google Scholar

The Coronary Drug Project (1973) Design, methods, and baseline results. Circulation 47(3 suppl):I1–I50Google Scholar

The Coronary Drug Project Research Group (1973) Findings leading to discontinuation of the 2.5-mg day estrogen group. JAMA 226:652–657Google Scholar

The Digitalis Investigation Group (1997) The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336:525–533Google Scholar

The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group (1998) Prevention of cardiovascular events and death with Pravastatin in patients with coronary heart disease and a broad range in initial cholesterol levels. N Engl J Med 339:1349–1357Google Scholar

The Systolic Hypertension in the Elderly Program Cooperative Research Group (1993) Implications of the systolic hypertension in the elderly program. Hypertension 21:335–343Google Scholar

The Writing Group for the PEPI Trial (1995) Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 273:199–208Google Scholar

Torp Pedersen C, The Danish Investigations of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group (1998) Dofetilide: a new Class III antiarrhythmic drug which is safe in patients with congestive heart failure. J Am Coll Cardiol:160AGoogle Scholar

Tresch D, Heudebert G, Kutty K et al (1994) Cardiopulmonary resuscitation in elderly patients hospitalized in the 1990s: a favorable outcome. J Am Geriatr Soc 42:137–141PubMedGoogle Scholar

Tresch DD, Neahring JM, Duthie EH et al (1993) Outcomes of cardiopulmonary resuscitation in nursing homes: can we predict who will benefit? Am J Med 95: 123–130CrossRefPubMedGoogle Scholar

UK Propafenone PSVT Study Group (1995) A randomized placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. Circulation 92:2550–2557Google Scholar

Van der Hoeven JG, Roos AN (1992) Resuscitation after cardiac arrest outside the hospital. N Engl J Med 326:1495–1496Google Scholar

Van Gelder IC, Hagens VE, Bosker HA et al (2002) A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347:1834–1840CrossRefPubMedGoogle Scholar

Van Hoeyweghen RJ, Bossaert LL, Mullie A et al (1992) Survival after out-of-hospital cardiac arrest in elderly patients. Belgian Cerebral Resuscitation Study Group. Ann Emerg Med 21:1179–1184CrossRefPubMedGoogle Scholar

Vaughan Williams EM (1975) Classification of antidysrhythic drugs. Pharmac Therap Bull 1:115Google Scholar

Viscoli CM, Brass LM, Kernan WN et al (2001) A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 345(17):1243–1249CrossRefPubMedGoogle Scholar

Wagg A, Kninirons M, Stewart K (1995) Cardiopulmonary resuscitation: doctors and nurses expect too much. J R Coll Physicians of London 29:20–24Google Scholar

Wakatsuki A, Ikenoue N, Sagara Y (1998) Effects of estrogen on susceptibility to oxidation of low-density and high-density lipoprotein in postmenopausal women. Maturitas 28:229–234CrossRefPubMedGoogle Scholar

Waldo AL (2002) Long-term pharmacologic management of atrial fibrillation in the elderly. Am J Geriatr Cardiol 11:233–244, 256PubMedGoogle Scholar

Waldo AL, Camm AJ, de Ruyter H et al, for the SWORD Investigators (1996) Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 348:7–12CrossRefPubMedGoogle Scholar

Walsh BW, Schiff I, Rosner B et al (1991) Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 325:1196–1204PubMedGoogle Scholar

Wellens HJJ, Lau CP, Lüderitz B et al (1998) Atrioverter: an implantable device for the treatment of atrial fibrillation. Circulation 98:1651–1656PubMedGoogle Scholar

Wijffels MCEF, Kirchhof CJHJ, Dorland R et al (1995) Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92:1954–1968PubMedGoogle Scholar

Women’s Health Initiative (2002) HRT Update June 2001. Available at: http://www.nhlbi.nih.gov/whi/HRTUpdate2001.pdfGoogle Scholar

Women’s Health Initiative Study Group (1998) Design of a women’s health initiative clinical trial and observational study. Control Clin Trials 19:61–109Google Scholar

Wong CK, Lau CP, Leung WH et al (1990) Usefulness of labetalol in chronic atrial fibrillation. AM J Cardiol 66:1212–1215CrossRefPubMedGoogle Scholar

Yadav A, Scheinman M (2003) Atrial fibrillation in the elderly. Am J Geriatr Cardiol 12:49–56PubMedGoogle Scholar

Yusuf B, Peto R, Lewis J et al (1985) β-blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 27:335–371PubMedGoogle Scholar

Yusuf S, Wittes J, Friedman L (1988) Overview of results of randomized clinical trials in heart disease. JAMA 260:2088–2093CrossRefPubMedGoogle Scholar

Zipes DB (1997) Specific arrhythmias: diagnosis and treatment. In: Braunwald EB (ed) Heart disease: a text book of cardiovascular medicine, 5^th edn. WB Saunders Company, Philadelphia, PA, p 656Google Scholar